Dr. Richard Insel Discusses Diabetes Research

  • Recommend
  • Tweet
  • Print
  • Email

BIOtech Now interviews Dr. Richard A. Insel, Executive Vice President, Research for the Juvenile Diabetes Research Foundation International (JDRF) regarding JDRF's use of venture philanthropy models to advance research leading to a cure for type 1 diabetes. JDRF is the leader in research leading to a cure for type 1 diabetes in the world.  It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal.  Since its founding in 1970 by parents of children with type 1 diabetes, JDRF has awarded more than $1.3 billion to diabetes research, including more than $156 million in FY2008.  In FY2008, the Foundation funded more than 1,000 centers, grants in laboratories, hospitals, and industry, and fellowships in 22 countries. Dr. Insel discusses JDRF's mission and previews presentations about JDRF's recent and current research efforts at the 11th Annual BIO CEO & Investor Conference Februrary 9-10, 2009 and the upcoming 2009 BIO International Convention in Atlanta. Listen or download the program here.